United Capital Financial Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.35M Buy
267,448
+41,529
+18% +$990K 0.04% 326
2026
Q1
$5.37M Buy
225,919
+27,921
+14% +$673K 0.03% 351
2025
Q4
$4.79M Buy
197,998
+50,607
+34% +$1.22M 0.03% 360
2025
Q3
$3.56M Buy
147,391
+25,850
+21% +$622K 0.03% 352
2025
Q2
$2.92M Buy
121,541
+44,758
+58% +$1.06M 0.02% 370
2025
Q1
$1.82M Buy
76,783
+39,074
+104% +$923K 0.02% 443
2024
Q4
$884K Buy
+37,709
New +$895K 0.01% 583

Other funds holding IBD

United Capital Financial Advisors's IBD Position: Q2 2026 in Review

United Capital Financial Advisors increased its Inspire Corporate Bond ETF (IBD) stake by 18% in Q2 2026, buying an estimated $990K and bringing the position to 267,448 shares worth $6.35M. The position accounts for 0.04% of the portfolio, ranked #326.

United Capital Financial Advisors first reported a position in IBD in Q4 2024 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • United Capital Financial Advisors held 267,448 shares of Inspire Corporate Bond ETF worth $6.35M as of Q2 2026.
  • United Capital Financial Advisors bought 41,529 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $990K.
  • Inspire Corporate Bond ETF made up 0.04% of United Capital Financial Advisors's portfolio in Q2 2026, its #326 holding.
  • United Capital Financial Advisors first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 7 quarters since.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.